Last reviewed · How we verify

NCT05096767

Neuropathic Spinal Pain Descriptors in Ankylosing Spondylitis

Recruiting now Last updated 7 March 2025
What this trial tests

trial testing questionnaires and inventories in Ankylosing Spondylitis in 130 participants. Currently enrolling.

Timeline
15 October 2021
Primary endpoint
25 November 2025
25 December 2025

Quick facts

Lead sponsorBozyaka Training and Research Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment130
Start date15 October 2021
Primary completion25 November 2025
Estimated completion25 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bozyaka Training and Research Hospital

Who can join

Adults 18 to 70, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have aimed to explore and interpret the neuropathic pain (NP) descriptors of spinal pain in patients with ankylosing spondylitis (AS). For this purpose they have attempted to initiate a prospective, cross-sectional study with AS patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaires and inventories

Trials testing the same drug.

Other recruiting trials for Ankylosing Spondylitis

Currently open trials in the same condition.

Other Bozyaka Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05096767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing